WHO Issues Alert Over Severe Shortage of Obesity Jabs
Fewer than a tenth of patients eligible to benefit from weight-loss injections like Wegovy can access them, warns the global health agency as it issues its initial recommendations on the therapies.
With over a billion individuals worldwide currently classified as obese, it is advocating for increased and just access to this class of drugs.
Per estimates, over two billion could be living with obesity by 2030 if no action is taken.
"The latest guidelines acknowledges that obesity is a chronic disease that can be addressed with comprehensive and continuous care," stated WHO director-general Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and supply-chain constraints are significant barriers to universal access to the treatments that can aid individuals in losing considerable weight, says the organization.
Weight-Loss Drug Scarcity
Despite the current most favorable scenario, the manufacturing of these medications would only suffice for around 100 million people – under 10% of those who need them, according to the health organization.
The advice calls on nations and manufacturers to widen access, via approaches such as licensing agreements.
Exclusive production rights on the active ingredient – the primary component of a leading brand – is scheduled to end in multiple nations in 2026.
How Weight-Loss Injections Operate
The injections imitate a biological compound to delay gastric emptying, curb appetite and boost feelings of fullness so individuals consume fewer calories.
Patients usually see weight reduction after several weeks of beginning the regular doses.
Evidence indicates people may see weight return within a year of halting the treatment, because their typical hunger come back.
To be carrying excess weight raises your risk for experiencing medical conditions, including type 2 diabetes, heart disease, brain attack, and specific malignancies.
Excess weight affects individuals in all nations and was linked to over three and a half million deaths worldwide in 2024, as per the health agency.
